Cancer patients face high thrombosis risk in new study

New international research findings presented at the Pan-European Cardiology Congress in Munich highlight a significant cardiovascular risk for cancer patients. Data from the Arterial Cancer Associated Thrombosis research program indicates that approximately 8% of cancer patients are at risk of acute coronary events, such as myocardial infarction, ischemic stroke, or peripheral artery thrombosis.

When combined with the 10% of patients at risk of venous thrombosis, the total risk reaches approximately 20%, meaning one in five cancer patients may suffer some form of thrombosis. The study involved 1,064 cancer patients with a median age of 65, 72% of whom had advanced or metastatic disease.

The multinational program is coordinated by Professor Gregory Gerotziapas of Sorbonne University and includes research teams from Greece (National and Kapodistrian University of Athens), Russia (Sechenov University), and the United States (Loyola University Chicago). Future research aims to utilize AI models to more accurately predict which patients are at the highest risk.